These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 40904)

  • 21. Contraception in diabetic women.
    Skouby SO; Mølsted-Pedersen L; Kühl C
    Acta Endocrinol Suppl (Copenh); 1986; 277():125-9. PubMed ID: 3532663
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of administration and withdrawal of oral contraceptive pills on serum lipids and lipoproteins.
    Arora S; Arora RC; Garg RK; Agarwal N; Nautiyal A
    Indian J Physiol Pharmacol; 1988; 32(1):67-71. PubMed ID: 3169963
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of a combined oral contraceptive pill in black Zimbabwean women.
    Kasule J; Mbizvo M; Makuyana D; Masona D
    Cent Afr J Med; 1991 Dec; 37(12):403-9. PubMed ID: 1806254
    [TBL] [Abstract][Full Text] [Related]  

  • 24. European Society of Contraception oral contraceptives survey update: birth control methods in "Europe of the 12".
    Serfaty D; Wildemeersch D; Verougstraete A; Creatsas G
    Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():73-9. PubMed ID: 8574253
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolic effects of two low-dose triphasic oral contraceptives containing ethinyl estradiol and levonorgestrel or gestodene.
    Lepot MR; Gaspard UJ
    Int J Fertil; 1987; 32 Suppl():15-20. PubMed ID: 2906343
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Oral contraceptives and metabolic changes].
    Lara Ricalde R; Aznar Ramos R
    Ginecol Obstet Mex; 1986 Aug; 54():212-5. PubMed ID: 3781292
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pill formulations and their effect on lipid and carbohydrate metabolism.
    Brooks PG
    J Reprod Med; 1984 Jul; 29(7 Suppl):539-46. PubMed ID: 6481707
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Defects in carbohydrate metabolism in oral contraceptive users without apparent metabolic risk factors.
    Watanabe RM; Azen CG; Roy S; Perlman JA; Bergman RN
    J Clin Endocrinol Metab; 1994 Nov; 79(5):1277-83. PubMed ID: 7962320
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prospective studies of carbohydrate metabolism in "normal" women using norgestrel for eighteen months.
    Spellacy WN; Buhi WC; Birk SA
    Fertil Steril; 1981 Feb; 35(2):167-71. PubMed ID: 7009219
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studies of blood glucose and plasma insulin in "normal" women using mechanical contraception for 6 months.
    Spellacy WN; Buhi WC; Birk SA
    Am J Obstet Gynecol; 1975 Dec; 123(8):786-9. PubMed ID: 1106200
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of norgestrel on carbohydrate and lipid metabolism over one year.
    Spellacy WN; Buhi WC; Birk SA
    Am J Obstet Gynecol; 1976 Aug; 125(7):984-6. PubMed ID: 941954
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Studies of carbohydrate and lipid metabolism in women using the progesterone-T intrauterine device for six months: blood glucose, insulin, cholesterol, and triglyceride levels.
    Spellacy WN; Buhi WC; Birk SA
    Fertil Steril; 1978 May; 29(5):505-8. PubMed ID: 668930
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of daily 30 MCG norgestrel on glucose, insulin, cholesterol and triglycerides during 1 year's time of use.
    Boonsiri B; Virutamasen P; Tangkeo P; Wongsrichanalai C
    Asia Oceania J Obstet Gynaecol; 1983 Jun; 9(2):180-4. PubMed ID: 6351820
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of estrogens, progestogen, oral contraceptives, and intrauterine devices on fasting triglyceride and insulin levels.
    Spellacy WN; Buhi WC; Birk SA; Cabal R
    Fertil Steril; 1973 Mar; 24(3):178-84. PubMed ID: 4691359
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of oral contraceptives on carbohydrate and lipid metabolism.
    Gupta SC; Sinha M; Rajvanshi VS; Samant V; Indrayan A
    Indian J Med Res; 1971 Nov; 59(11):1712-9. PubMed ID: 5143163
    [No Abstract]   [Full Text] [Related]  

  • 36. Carbohydrate tolerance and serum lipid responses to type of dietary carbohydrate and oral contraceptive use in young women.
    Moser PB; Behall KM; Kelsay JL; Prather ES
    J Am Coll Nutr; 1986; 5(1):45-53. PubMed ID: 3517111
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carbohydrate metabolism in women receiving d-norgestrel for postcoital contraception.
    Garmendia F; Urdanivia E; Kesserü E
    Horm Metab Res; 1979 Jan; 11(1):81-2. PubMed ID: 428916
    [No Abstract]   [Full Text] [Related]  

  • 38. Serum triglyceride in women with and without a predisposition to diabetes during short-term administration of a combined oral contraception.
    Nelson FH
    Acta Obstet Gynecol Scand; 1974; 53(1):13-9. PubMed ID: 4817622
    [No Abstract]   [Full Text] [Related]  

  • 39. Blood glucose, insulin, cholesterol and triglyceride levels in women treated for six months with the weekly oral contraceptive R2323.
    Spellacy WN; Mahan CS; Buhi WC; Dumbaugh VA; Birk SA
    Contraception; 1978 Aug; 18(2):121-6. PubMed ID: 249676
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of extended regimens of the contraceptive vaginal ring on carbohydrate metabolism.
    Guazzelli CA; Barreiros FA; Torloni MR; Barbieri M
    Contraception; 2012 Mar; 85(3):253-6. PubMed ID: 22067767
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.